TB
Insider
Timothy C Barabe
DirectorTimothy C Barabe (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in RNAC. Across 1 priced purchase filing, the average 21-session return was +4.4% from execution and +11.3% from disclosure (delay-adjusted; derived). The largest single filing was $206K of RNAC (30,000 sh × $6.86, as filed), executed Dec 4 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+4.4%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+11.3%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
4d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$206K
shares × price, as filed
Last traded
Dec 4 2025
Filed Dec 8 2025
Volume by month
Buys $206K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Not on file
1 filing
Sector per market data · by filing · past 12 months
Most traded names
RNAC
RNAC
RNAC · 1 buy · 0 sells
1 filing
Recent filings
RNACPURCHASE
Cartesian Therapeutics, Inc.
View filing →
$206K30,000 sh × $6.86
Exec Dec 4 2025
Filed Dec 8 2025 · 4:07 PM ET